Airsculpt Technologies Financials

AIRS Stock  USD 5.35  0.14  2.55%   
Based on the key indicators related to Airsculpt Technologies' liquidity, profitability, solvency, and operating efficiency, Airsculpt Technologies may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Airsculpt Technologies' Total Current Assets are comparatively stable compared to the past year. Key indicators impacting Airsculpt Technologies' financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.590.9168
Way Down
Slightly volatile
Current Ratio1.180.7857
Way Up
Slightly volatile
Investors should never underestimate Airsculpt Technologies' ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Airsculpt Technologies' cash flow, debt, and profitability to make informed and accurate decisions about investing in Airsculpt Technologies.

Net Income

(4.26 Million)

  
Understanding current and past Airsculpt Technologies Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Airsculpt Technologies' financial statements are interrelated, with each one affecting the others. For example, an increase in Airsculpt Technologies' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Airsculpt Technologies' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Airsculpt Technologies. Check Airsculpt Technologies' Beneish M Score to see the likelihood of Airsculpt Technologies' management manipulating its earnings.

Airsculpt Technologies Stock Summary

Airsculpt Technologies competes with Acadia Healthcare, Pennant, Amedisys, Ensign, and Universal Health. AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida. Airsculpt Technologies operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 240 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS0094961002
CUSIP009496100
LocationFlorida; U.S.A
Business Address1111 Lincoln Road,
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websiteelitebodysculpture.com
Phone786 709 9690
CurrencyUSD - US Dollar

Airsculpt Technologies Key Financial Ratios

Airsculpt Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Airsculpt Technologies's current stock value. Our valuation model uses many indicators to compare Airsculpt Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Airsculpt Technologies competition to find correlations between indicators driving Airsculpt Technologies's intrinsic value. More Info.
Airsculpt Technologies is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Airsculpt Technologies' Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Airsculpt Technologies by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Airsculpt Technologies Systematic Risk

Airsculpt Technologies' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Airsculpt Technologies volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Airsculpt Technologies correlated with the market. If Beta is less than 0 Airsculpt Technologies generally moves in the opposite direction as compared to the market. If Airsculpt Technologies Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Airsculpt Technologies is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Airsculpt Technologies is generally in the same direction as the market. If Beta > 1 Airsculpt Technologies moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Airsculpt Technologies Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Airsculpt Technologies' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Airsculpt Technologies growth as a starting point in their analysis.

Price Earnings To Growth Ratio

1.43

At this time, Airsculpt Technologies' Price Earnings To Growth Ratio is comparatively stable compared to the past year.

Airsculpt Technologies December 23, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Airsculpt Technologies help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Airsculpt Technologies. We use our internally-developed statistical techniques to arrive at the intrinsic value of Airsculpt Technologies based on widely used predictive technical indicators. In general, we focus on analyzing Airsculpt Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Airsculpt Technologies's daily price indicators and compare them against related drivers.

Additional Tools for Airsculpt Stock Analysis

When running Airsculpt Technologies' price analysis, check to measure Airsculpt Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Airsculpt Technologies is operating at the current time. Most of Airsculpt Technologies' value examination focuses on studying past and present price action to predict the probability of Airsculpt Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Airsculpt Technologies' price. Additionally, you may evaluate how the addition of Airsculpt Technologies to your portfolios can decrease your overall portfolio volatility.